Question 1

What is the catalog number for Epidermal Growth Factor (EGF) Recombinant, Canine?

Accepted Answer

The catalog number for Epidermal Growth Factor (EGF) Recombinant, Canine is 154446.

Question 2

What sizes are available for Epidermal Growth Factor (EGF) Recombinant, Canine?

Accepted Answer

Epidermal Growth Factor (EGF) Recombinant, Canine is available in the following size(s): 10 µg, 50 µg, 200 µg.

Question 3

How many pack sizes does Epidermal Growth Factor (EGF) Recombinant, Canine come in?

Accepted Answer

Epidermal Growth Factor (EGF) Recombinant, Canine is available in 3 different pack sizes.

Question 4

Is Epidermal Growth Factor (EGF) Recombinant, Canine in stock?

Accepted Answer

Epidermal Growth Factor (EGF) Recombinant, Canine is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 6

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 7

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Epidermal Growth Factor (EGF) Recombinant, Canine

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

Diphenylacetylene

ACRV1 (NM_020113) Human Over-expression Lysate

Natural Convection Oven BONC-5703

Teneligliptin Hydrobromide (2:5)

Frozen Tissue Sections, Skin

Vedolizumab Biosimilar - Research Grade